Lagoda Investment Management’s Pfizer PFE Stock Holding History

Lagoda Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,292	Closed	-$44K	–	38
2018 Q1	$44K	Hold	1,292	–	–	0.02%	34
2017 Q4	$44K	Hold	1,292	–	–	0.02%	38
2017 Q3	$44K	Hold	1,292	–	–	0.02%	37
2017 Q2	$41K	Hold	1,292	–	–	0.02%	35
2017 Q1	$42K	Hold	1,292	–	–	0.02%	32
2016 Q4	$40K	Sell	1,292 -265	-17%	-$8.09K	0.01%	37
2016 Q3	$50K	Sell	1,557 -63	-4%	-$2.11K	0.02%	25
2016 Q2	$54K	Hold	1,620	–	–	0.02%	24
2016 Q1	$46K	Sell	1,620 -84	-5%	-$2.4K	0.02%	26
2015 Q4	$52K	Hold	1,704	–	–	0.01%	29
2015 Q3	$51K	Hold	1,704	–	–	0.01%	28
2015 Q2	$54K	Hold	1,704	–	–	0.01%	26
2015 Q1	$56K	Sell	1,704 -273	-14%	-$8.68K	0.02%	26
2014 Q4	$58K	Buy	+1,977	New	+$56.7K	0.02%	35

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lagoda Investment Management's PFE Position: Q2 2018 in Review

Lagoda Investment Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 1,292 shares — an estimated $44K sold.

Lagoda Investment Management first reported a position in PFE in Q4 2014 and held it in 14 quarters. The position peaked at $58K in Q4 2014. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Lagoda Investment Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Lagoda Investment Management sold 1,292 Pfizer shares in Q2 2018, an estimated $44K.
Lagoda Investment Management first reported a position in Pfizer in Q4 2014 and held it in 14 quarters.
Lagoda Investment Management's Pfizer position peaked at $58K in Q4 2014.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Lagoda Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.